1.Liver support therapy with molecular adsorbents recirculating system in liver failure: a summary of 252 cases from 14 centers in China.
Min-min WANG ; Shi-jun CHEN ; Qi-fa YE ; Yi-jun YANG ; Shi-bin CHEN ; Xin-min ZHOU ; Li-min GUO ; Yue-xin ZHANG ; Xiao-qiang DING ; Xiao-bin HU ; Hong-tao LUO ; Yi-he LIU ; Wen-ya WANG
Chinese Medical Journal 2008;121(21):2197-2201
BACKGROUNDA liver support therapy, named molecular adsorbents recirculating system (MARS), has been used for more than 700 liver failure patients in China. We made here a summary to evaluate the effects of MARS treatment in different applications with emphasis on hepatitis B virus (HBV) based liver failure.
METHODSThis report analyzed data of 252 patients (mean age (44.9+/- 12.7) years) in three groups: acute severe hepatitis (ASH), subacute severe hepatitis (SSH) and chronic severe hepatitis (CSH). The largest group was CSH (156 patients, 61.9%), and 188 patients (74.6%, 188/252) were infected with HBV.
RESULTSMARS treatments were associated with significant reduction of albumin bound toxins and water-soluble toxins. Most of the patients showed a positive response with a significant improvement of multiple organ function substantiated by a significant increase in prothrombin time activity (PTA) and median arterial pressure (MAP). There was a decrease in hepatic encephalopathy (HE) grade and Child-Turcotte-Pugh (CTP) scale. Thirty-nine of 188 HBV patients (20.7%) dropped out of the commendatory consecutive therapy ending with lower survival of 43.6% while the rest of the 149 patients had a survival rate of 62.4%. Survival within the ASH and SSH groups were 81.2% and 75.0%, respectively. In the CSH group, end stage patients were predominant (65/151, 43%), whereas the early and middle stage patients had a better prognosis: early stage survival, including orthotopic liver transplantation (OLT) survival of 91.7%, middle stage survival of 75%, end stage survival of 33.8%.
CONCLUSIONSMARS continues to be the most favorable extracorporeal treatment for liver support therapy in China for a wide range of conditions, including the majority of hepatitis B related liver failure conditions. The appropriate application of MARS for the right indications and stage of hepatic failure, as well as the fulfillment of prescribed treatments, will lead to the optimal therapeutic result.
Humans ; Liver Failure ; mortality ; therapy ; Renal Dialysis ; Sorption Detoxification ; adverse effects ; methods
2.Analysis of Factors Associated with Death in Maintenance Hemodialysis Patients: A Multicenter Study in China.
Kang-Kang SONG ; De-Long ZHAO ; Yuan-Da WANG ; Yong WANG ; Xue-Feng SUN ; Li-Ning MIAO ; Zhao-Hui NI ; Hong-Li LIN ; Fu-You LIU ; Ying LI ; Ya-Ni HE ; Nian-Song WANG ; Cai-Li WANG ; Ai-Hua ZHANG ; Meng-Hua CHEN ; Xiao-Ping YANG ; Yue-Yi DENG ; Feng-Min SHAO ; Shu-Xia FU ; Jing-Ai FANG ; Guang-Yan CAI ; Xiang-Mei CHEN
Chinese Medical Journal 2017;130(8):885-891
BACKGROUNDPatients on hemodialysis have a high-mortality risk. This study analyzed factors associated with death in patients on maintenance hemodialysis (MHD). While some studies used baseline data of MHD patients, this study used the most recent data obtained from patients just prior to either a primary endpoint or the end of the study period to find the characteristics of patients preceding death.
METHODSParticipants were selected from 16 blood purification centers in China from January 2012 to December 2014. Patients' data were collected retrospectively. Based on survival status, the participants were divided into two groups: survival group and the death group. Logistic regression analysis was performed to determine factors associated with all-cause mortality.
RESULTSIn total, 4104 patients (57.58% male, median age 59 years) were included. Compared with the survival group, the death group had more men and more patients with diabetic nephropathy (DN) and hypertensive nephropathy. The patients preceding death also had lower levels of diastolic blood pressure, hemoglobin, serum albumin, serum calcium, serum phosphate, Kt/V, and higher age. Multivariate analysis revealed that male sex (odd ratio [OR]: 1.437, 95% confidence interval [CI]: 1.094-1.886), age (OR: 1.046, 95% CI: 1.036-1.057), and presence of DN (OR: 1.837, 95% CI: 1.322-2.552) were the risk factors associated with mortality. High serum calcium (OR: 0.585, 95% CI: 0.346-0.989), hemoglobin (OR: 0.974, 95% CI: 0.967-0.981), albumin (OR: 0.939, 95% CI: 0.915-0.963) levels, and dialysis with noncuffed catheter (OR: 0.165, 95% CI: 0.070-0.386) were protective factors based on a multivariate analysis.
CONCLUSIONSHemodialysis patients preceding death had lower hemoglobin, albumin, and serum calcium levels. Multivariate analysis showed that male sex, age, DN, low hemoglobin, low albumin, and low serum calcium were associated with death in hemodialysis patients.
Adult ; Aged ; China ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Renal Dialysis ; adverse effects ; mortality ; Retrospective Studies ; Risk Factors
3.Impact of dialysis modality on technique survival in end-stage renal disease patients.
Jong Hak LEE ; Sun Hee PARK ; Jeong Hoon LIM ; Young Jae PARK ; Sang Un KIM ; Kyung Hee LEE ; Kyung Hoon KIM ; Seung Chan PARK ; Hee Yeon JUNG ; Owen KWON ; Ji Young CHOI ; Jang Hee CHO ; Chan Duck KIM ; Yong Lim KIM
The Korean Journal of Internal Medicine 2016;31(1):106-115
BACKGROUND/AIMS: This study analyzed the risk factors for technique survival in dialysis patients and compared technique survival rates between hemodialysis (HD) and peritoneal dialysis (PD) in a prospective cohort of Korean patients. METHODS: A total of 1,042 patients undergoing dialysis from September 2008 to June 2011 were analyzed. The dialysis modality was defined as that used 90 days after commencing dialysis. Technique survival was compared between the two dialysis modalities, and the predictive risk factors were evaluated. RESULTS: The dialysis modality was an independent risk factor predictive of technique survival. PD had a higher risk for technique failure than HD (hazard ratio [HR], 10.8; 95% confidence interval [CI], 1.9 to 62.0; p = 0.008) during a median follow-up of 11.0 months. In the PD group, a high body mass index (BMI) was an independent risk factor for technique failure (HR, 1.3; 95% CI, 1.0 to 1.8; p = 0.036). Peritonitis was the most common cause of PD technique failure. The difference in technique survival between PD and HD was more prominent in diabetic patients with a good nutritional status and in non-diabetic patients with a poor nutritional status. CONCLUSIONS: In a prospective cohort of Korean patients with end-stage renal disease, PD was associated with a higher risk of technique failure than HD. Diabetic patients with a good nutritional status and non-diabetic patients with a poor nutritional status, as well as patients with a higher BMI, had an inferior technique survival rate with PD compared to HD.
Adult
;
Aged
;
Body Mass Index
;
Humans
;
Kidney Failure, Chronic/diagnosis/mortality/*therapy
;
Male
;
Middle Aged
;
Nutritional Status
;
Peritoneal Dialysis/adverse effects/mortality
;
Prospective Studies
;
*Renal Dialysis/adverse effects/mortality
;
Republic of Korea
;
Risk Factors
;
Time Factors
;
Treatment Outcome
4.Comparative Study of Renal Replacement Therapy in Korean Diabetic End-Stage Renal Disease Patients: a Single Center Study.
So Rae CHOI ; Sang Cheol LEE ; Beom Seok KIM ; Soo Young YOON ; Hyeong Cheon PARK ; Shin Wook KANG ; Kyu Hun CHOI ; Yu Seun KIM ; Seung Kyu HA ; Ki Il PARK ; Dae Suk HAN ; Ho Yung LEE
Yonsei Medical Journal 2003;44(3):454-462
The number of diabetic ESRD patients has increased and death rates of diabetic patients on hemodialysis (HD), peritoneal dialysis (PD) and renal transplantation (RT) have remained higher than the death rate of non-diabetic patients. An attempt was made to compare the clinical characteristics, patients' cumulative survival, and technical survival among the three groups retrospectively according to the mode of renal replacement therapy (RRT), and to analyze the risk factors associated with mortality. A total of 229 diabetic ESRD patients diagnosed between 1986 and 1995 at the Severance Hospital who began dialysis or who underwent a kidney transplant were included and their medical charts were reviewed. Hypertension was the most common co-morbid disease in all study groups. The prevalence of cardiovascular disease was the only co-morbid condition that was significantly different among the three groups, which was highest in the PD group (24.4%) and lowest in the RT group (8%). In the analysis of a patient's cumulative survival rate not adjusted for age and sex, the RT group had the highest survival rate, and the cumulative survival rate of the HD and PD group were similar. The 5-year survival rate of the patients treated with HD, PD and RT was 28.8%, 19.8%, and 72.0%, respectively. No differences were observed in the patient's cumulative survival rate between the HD and PD patients even when it was adjusted for age. When adjusted for age, sex and risk factors, the relative death rate of the RT group was significantly lower in male patients younger than 60 years of age. With the exception of male patients younger than 60 years of age, the PD group showed a slightly lower relative death rate although it was not significant. The multiple Cox regression analysis of patient survival showed that age, serum albumin, BUN, mean hospital days, the presence of cardiovascular disease at the initiation of RRT were associated with mortality. The analysis of the technique survival rate revealed a better result in the HD group compared to PD group, but a limitation in being able to investigate the AVF function disturbed the accuracy of the analysis of technical survival rate. In conclusion, the survival rate between the PD and HD patients was not different and the RT group had the best survival rate. Therefore, kidney transplantation in diabetic ESRD patients should be considered positively if no other contraindicated condition for RT exit.
Aged
;
Comparative Study
;
Female
;
Human
;
Kidney Failure, Chronic/mortality/*therapy
;
*Kidney Transplantation/adverse effects
;
Korea
;
Male
;
Middle Aged
;
*Peritoneal Dialysis/adverse effects
;
*Renal Dialysis/adverse effects
;
Retrospective Studies
;
Survival Analysis
5.Evaluation of the renal replacement therapy on the liver transplant patients with acute renal failure.
Jin-zhong YUAN ; Qi-fa YE ; Hao ZHANG ; Ying-zi MING ; Ming GUI ; Ying JI ; Jian SUN ; Jian-wen WANG ; Zu-hai REN ; Ke CHENG ; Yu-jun ZHAO ; Pei-long SUN ; Kun WU ; Long-zhen JI
Chinese Journal of Hepatology 2009;17(5):334-337
OBJECTIVETo analyze the preoperative risk factors on liver transplant recipients with acute renal failure(ARF), and to evaluate renal replacement therapy (RRT) as a transitonary therapy before liver transplantation.
METHODSLiver transplant recipients with acute renal failure treated with renal replacement therapy between January 1st, 2001 and January 1st, 2008 in our center were retrospected. Clinical characteristics, the kinds of RRT and prognosis were analyzed; Logistic regression was applied to analyze the parameters that can forecast the motality of the liver transplant recipients with acute renal failure.
RESULTSOf the patients who received RRT, 30% survived to liver transplantation, 67.5% died while waiting for liver transplantation. The dead had a higher multiple organ dysfunction score (MODS), and lower mean arterial pressure than those survived to liver transplantation. There was no significant difference in the duration of RRT between continuous renal replacement therapy (CRRT) patients and hemodialysis patients. CRRT patients had a higher MODS, lower mean arterial pressure, lower serum creatinine than hemodialysis patients. Lower mean arterial pressure was statistically associated with higher risk of mortality.
CONCLUSIONThough mortality was high, RRT helps part (30%) of patients survive to liver transplantation. Therefore, considering the high mortality without transplantation, RRT is acceptable for liver transplant recipients with ARF.
Acute Kidney Injury ; etiology ; mortality ; therapy ; Adult ; Blood Pressure ; Female ; Humans ; Liver Transplantation ; adverse effects ; Liver, Artificial ; Male ; Middle Aged ; Prognosis ; Regression Analysis ; Renal Dialysis ; methods ; Renal Replacement Therapy ; mortality ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Survival Analysis
6.Major changes and improvements of dialysis therapy in Korea: review of end-stage renal disease registry.
The Korean Journal of Internal Medicine 2015;30(1):17-22
The Korean Society of Nephrology (KSN) launched a nationwide end-stage renal disease (ESRD) patient registry in 1985 called the Insan Prof. Byung-Suk Min Memorial ESRD Patient Registry. KSN members voluntarily participate in this registry, which has been collecting data through the Internet since 2000. The KSN ESRD patient registry data were reviewed to elucidate the major changes and improvements in dialysis therapy in Korea. The data review revealed: a rapid increase in the number of patients with ESRD; an increase in the number of patients with diabetic nephropathy; a decrease in the proportion of patients undergoing peritoneal dialysis; an increase in the role of private dialysis clinics; an increase in the number of elderly patients undergoing dialysis and the number of patients undergoing long-term dialysis; a decrease in mean blood pressure and an increase in pulse pressure; improvement in anemia treatment; improvement in dialysis adequacy; and improvement in the survival of patients undergoing dialysis. In conclusion, improvements have been made in blood pressure control, anemia treatment, and dialysis adequacy despite increases in the number of elderly patients, diabetic patients, and patients on long-term dialysis during the last two decades in Korea.
Diabetic Retinopathy/diagnosis/mortality/*therapy
;
Humans
;
Kidney Failure, Chronic/diagnosis/mortality/*therapy
;
Peritoneal Dialysis/trends
;
Private Sector/trends
;
Quality Improvement/trends
;
Quality Indicators, Health Care/trends
;
Registries
;
Renal Dialysis/adverse effects/mortality/standards/*trends
;
Republic of Korea/epidemiology
;
Risk Factors
;
Time Factors
;
Treatment Outcome
7.Diagnosis and treatment of infective endocarditis in chronic hemodialysis patients.
Jian-Ling TAO ; Jie MA ; Guang-Li GE ; Li-Meng CHEN ; Hang LI ; Bao-Tong ZHOU ; Yang SUN ; Wen-Ling YEA ; Qi MIAO ; Xue-Mei LI ; Xue-Wang LI
Chinese Medical Sciences Journal 2010;25(3):135-139
OBJECTIVETo analyze the clinical features of hemodialysis patients complicated by infective endo carditis.
METHODSThe clinical features of six such patients admitted to Peking Union Medical College Hospital during the year 1990 to 2009 were analyzed. All of them were diagnosed based on Chinese Children Diagnostic Criteria for Infective Endocarditis.
RESULTSThe average age of the six patients was 52.3 +/- 19.3 years old. Four were males. Vascular accesses at the onset of infective endocarditis were as follows: permanent catheters in three, temporary catheters in two, and arteriovenous fistula in one. Three were found with mitral valve involvement, two with aortic valve involvement, and one with both. Five vegetations were found by transthoracic echocardiography, and one by transesophageal echocardiography. Four had positive blood culture results. The catheters were all removed. Four of the patients were improved by antibiotics treatment, in which two were still on hemodialysis in the following 14-24 months and the other two were lost to follow-up. One patient received surgery, but died of heart failure after further hemodialysis for three months. One was well on maintenance hemodialysis for three months after surgery.
CONCLUSIONSInfective endocarditis should be suspected when hemodialysis patients suffer from long-term fever, for which prompt blood culture and transthoracic echocardiography confirmation could be performed. Transesophageal echocardiography could be considered even when transthoracic echocardiography produces negative findings. With catheters removed, full course of appropriate sensitive antibiotics and surgery if indicated could improve the outcome of chronic hemodialysis patients complicated by infective endocarditis.
Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents ; therapeutic use ; Echocardiography, Transesophageal ; Endocarditis ; diagnosis ; drug therapy ; mortality ; Female ; Humans ; Kidney Failure, Chronic ; therapy ; Male ; Middle Aged ; Renal Dialysis ; adverse effects ; Risk Factors
8.Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients.
Jung Eun LEE ; Hyung Jong KIM ; Sung Jin MOON ; Ji Sun NAM ; Jwa Kyung KIM ; Seung Kyu KIM ; Gi Young YUN ; Sung Kyu HA ; Hyeong Cheon PARK
The Korean Journal of Internal Medicine 2013;28(6):668-677
BACKGROUND/AIMS: Osteoprotegerin (OPG) and fetuin-A are vascular calcification regulators that may be related to high cardiovascular (CV) mortality in hemodialysis (HD) patients. We evaluated the relationship between OPG, fetuin-A, and pulse wave velocity (PWV), a marker of vascular stiffness, and determined whether OPG and fetuin-A were independent predictors of CV events in HD patients. METHODS: We conducted a prospective observational study in 97 HD patients. OPG and fetuin-A were measured at baseline and arterial stiffness was evaluated by PWV. All patients were stratified into tertiles according to serum OPG levels. RESULTS: A significant trend was observed across increasing serum OPG concentration tertiles for age, HD duration, systolic blood pressure, cholesterol, triglycerides, and PWV. Multiple linear regression analysis revealed that diabetes (beta = 0.430, p = 0.000) and OPG levels (beta = 0.308, p = 0.003) were independently associated with PWV. The frequency of new CV events was significantly higher in the upper OPG tertiles compared with those in the lower OPG tertiles. In Cox proportional hazards analysis, upper tertiles of OPG levels were significantly associated with CV events (hazard ratio = 4.536, p = 0.011). CONCLUSIONS: Serum OPG, but not fetuin-A, levels were closely associated with increased vascular stiffness, and higher OPG levels may be independent predictors of new CV events in HD patients.
Adult
;
Aged
;
Biological Markers/blood
;
Cardiovascular Diseases/blood/diagnosis/*etiology/mortality/physiopathology
;
Female
;
Humans
;
Kaplan-Meier Estimate
;
Linear Models
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Osteoprotegerin/*blood
;
Predictive Value of Tests
;
Prognosis
;
Proportional Hazards Models
;
Prospective Studies
;
Pulse Wave Analysis
;
*Renal Dialysis/adverse effects/mortality
;
Renal Insufficiency, Chronic/complications/diagnosis/mortality/*therapy
;
Risk Factors
;
Up-Regulation
;
*Vascular Stiffness
;
alpha-2-HS-Glycoprotein/analysis
9.The impact of high-flux dialysis on mortality rates in incident and prevalent hemodialysis patients.
Hyung Wook KIM ; Su Hyun KIM ; Young Ok KIM ; Dong Chan JIN ; Ho Chul SONG ; Euy Jin CHOI ; Yong Lim KIM ; Yon Su KIM ; Shin Wook KANG ; Nam Ho KIM ; Chul Woo YANG ; Yong Kyun KIM
The Korean Journal of Internal Medicine 2014;29(6):774-784
BACKGROUND/AIMS: The effect of high-flux (HF) dialysis on mortality rates could vary with the duration of dialysis. We evaluated the effects of HF dialysis on mortality rates in incident and prevalent hemodialysis (HD) patients. METHODS: Incident and prevalent HD patients were selected from the Clinical Research Center registry for end-stage renal disease (ESRD), a Korean prospective observational cohort study. Incident HD patients were defined as newly diagnosed ESRD patients initiating HD. Prevalent HD patients were defined as patients who had been receiving HD for > 3 months. The primary outcome measure was all-cause mortality. RESULTS: This study included 1,165 incident and 1,641 prevalent HD patients. Following a median 24 months of follow-up, the mortality rates of the HF and low-flux (LF) groups did not significantly differ in the incident patients (hazard ratio [HR], 1.046; 95% confidence interval [CI], 0.592 to 1.847; p = 0.878). In the prevalent patients, HF dialysis was associated with decreased mortality compared with LF dialysis (HR, 0.606; 95% CI, 0.416 to 0.885; p = 0.009). CONCLUSIONS: HF dialysis was associated with a decreased mortality rate in prevalent HD patients, but not in incident HD patients.
Aged
;
Chi-Square Distribution
;
Female
;
Humans
;
Incidence
;
Kaplan-Meier Estimate
;
Kidney Failure, Chronic/diagnosis/*mortality/*therapy
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Prevalence
;
Proportional Hazards Models
;
Prospective Studies
;
Registries
;
Renal Dialysis/adverse effects/methods/*mortality
;
Republic of Korea/epidemiology
;
Risk Factors
;
Time Factors
;
Treatment Outcome
10.Current Status of Dialysis Therapy in Korea.
The Korean Journal of Internal Medicine 2011;26(2):123-131
The number of patients with end-stage renal disease (ESRD) is rising very rapidly as the number of elderly and patients with diabetes increases in Korea. ESRD Registry Committee of the Korean Society of Nephrology (KSN) collected dialysis therapy data in Korea through an online registry program on the KSN website. The status of renal replacement therapy in Korea at the end of 2009 was as follows. First, total number of patients with ESRD was 56,396 (hemodialysis [HD], 37,391; peritoneal dialysis [PD], 7,618; functioning kidney transplant [KT], 11,387). The prevalence of ESRD was 1,113.6 patients per million population (PMP). Proportion of patients undergoing renal replacement therapy was 66.3% with HD, 13.5% with PD, and 20.2% with KT. Second, a total of 8,906 (HD, 6,540; PD, 1,125; KT, 1,241; incidence rate of 175.9 PMP) patients developed ESRD in 2009. Third, the most common primary causes of ESRD were diabetic nephropathy (45.4%), hypertensive nephrosclerosis (18.3%), and chronic glomerulonephritis (11.1%). Fourth, mean urea reduction rate was 67.5% and 73.8% in male and female patients, respectively, undergoing HD. Mean Kt/V was 1.38 in male patients and 1.65 in female patients. Fifth, the overall 5-year survival rate of male patients undergoing dialysis was 65.4% and that of female patients was 67.4%.
Adult
;
Aged
;
Anemia/drug therapy/etiology
;
Comorbidity
;
Erythropoietin, Recombinant/therapeutic use
;
Female
;
Hematinics/therapeutic use
;
Humans
;
Incidence
;
Kidney Failure, Chronic/mortality/*therapy
;
Male
;
Middle Aged
;
Prevalence
;
Registries
;
*Renal Dialysis/adverse effects/mortality
;
Republic of Korea/epidemiology
;
Risk Factors
;
Survival Rate
;
Time Factors
;
Treatment Outcome